Browse by Uncontrolled Keywords
Number of items: 4.
2017
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2017)
Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Annals of medicine, 48 (4).
pp. 224-34.
ISSN 0785-3890
DOI: https://doi.org/10.3109/07853890.2016.1157263
2016
Mamza, J;
Marlin, C;
Wang, C;
Chokkalingam, K;
Idris, I;
(2016)
DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes - A systematic review and meta-analysis.
Diabetes research and clinical practice, 116.
pp. 288-98.
ISSN 0168-8227
DOI: https://doi.org/10.1016/j.diabres.2016.04.029
Mamza, J;
Mehta, R;
Donnelly, R;
Idris, I;
(2016)
Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database.
Diabetes technology & therapeutics, 18 (2).
pp. 85-92.
ISSN 1520-9156
DOI: https://doi.org/10.1089/dia.2015.0052
2013
Goring, S;
Hawkins, N;
Wygant, G;
Roudaut, M;
Townsend, R;
Wood, I;
Barnett, AH;
(2013)
Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: A systematic review and network meta-analysis.
Diabetes, obesity & metabolism, 16.
pp. 433-442.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12239
Full text not available from this repository.